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Abstract: The effect of mass treatment on questionnaire results in the diagnosis of schistosomiasis mansoni was
examined in 267 school children in an endemic area of Tanzania by Kato-Katz analysis of fecal specimens. The
questionnaire asked for information about self-diagnosis, abdominal symptoms, blood in stools, history of wild
water contact, stool examination and medication for schistosomiasis, and knowledge of the disease. A logistic re-
gression analysis disclosed a significant association between schistosomiasis and “diarrhea” (p = 0.007; odds ratio,
32.0; confidence interval, 2.5 - 403.3) and “abdominal enlargement” (p = 0.003; odds ratio, 15.2; confidence inter-
val, 2.6 - 90.1) among 61 children who had no history of medication for schistosomiasis. The sensitivity and speci-
ficity of the model were 86% and 64%, respectively. In contrast, no significant correlation was observed either for
the 116 treated children, or for all the 267 children after the mass treatment. We conclude, therefore, that for chil-
dren who had no history of medication for schistosomiasis, the questionnaire for abdominal manifestations pro-
vides reliable information on S . mansoni infection. However, once a child takes medication, the questionnaire be-
comes unreliable. This observation suggests that immunomodulation by anti-schistosomiasis drugs that kill adult
worms exerts an effect on the appearance of abdominal manifestations and might explain the ambiguity of clinical
symptoms in chronically infested patients, except in terminal cases. Further studies are required to develop a sim-
ple, rapid and cost-effective diagnostic method for monitoring S. mansoni infection after medication in local areas
without resort to laboratory-based identification of schistosomiasis.
Key words: Schistosoma mansoni, self-diagnosis, selective mass treatment, Tanzania
INTRODUCTION
Schistosomiasis is one of the widespread parasitic dis-
eases with important public health implications in sub-
Saharan countries. Disease control depends mostly on
medication treatment, because praziquantel, the drug of
choice, is safe and relatively inexpensive [1]. Several ap-
proaches for community-based treatment have been devel-
oped, including mass treatment, selective population treat-
ment and selective group treatment [2]. The main target
population is school-age children between 5 and 15 years
old, because they show the highest prevalence and intensity
in the entire population [2, 3, 4] and because they are the
main source of the transmission of infection. Following
WHO recommendations, school-based mass treatment with
praziquantel has been conducted in many high prevalence
areas [5].
The strategy emphasizing school-based mass treatment,
however, is not cost-effective in low prevalence areas. The
prevalence usually declines to a low level after a series of
mass treatments in high prevalence areas. Subsequently, the
school-based mass treatment approach should be replaced
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with selective treatment. The most reliable diagnostic
method for Schistosoma mansoni (S. mansoni) infection is
detection of eggs in feces, with a rapid and simple Kato-
Katz thick smear stool examination being applied to this
end. However, well-trained health personnel and micro-
scopes are required for this laboratory diagnosis, and it is
laborious, time-consuming, and expensive. Therefore, a
similarly rapid and simple yet cost-effective individual di-
agnostic method is required. This kind of simple method
has been developed for the screening of Schistosoma hae-
matobium infection based on self-reported haematuria and
self-diagnosis [6, 7, 8, 9]. Regarding S. mansoni infection,
several morbidity studies have been carried out since the
early 1970s, before the discovery of an effective medication
(praziquantel). These studies found that S. mansoni fre-
quently causes abdominal pain, blood in stool, bloody diar-
rhea, diarrhea in general, hepatomegaly, and splenomegaly
[3, 10, 11, 12, 13, 14, 15, 16]. Based on theses studies, the
diagnosis by questionnaire approach has been conducted for
S. mansoni infection since 1985, initially focusing on sub-
jective symptoms and the observation of stool appearance.
But since studies reported low to moderate sensitivities and
specificities [17, 18, 19], the questionnaires have been ex-
tended to include anamnestic information such as water-
contact behavior [20, 21, 22, 23]. This approach, which
was undertaken in several endemic areas, disclosed the po-
tential of questionnaires for the identification of S. mansoni
infection on the individual level [17, 18, 20, 22, 23, 24].
Supportive evidence for the application of a questionnaire
for identification of S. mansoni , however, is still scarce, es-
pecially in the wake of mass treatment with praziquantel.
The purpose of this study was to evaluate the efficacy
of questionnaires in the assessment of S. mansoni in one en-
demic area, with reference to the history of praziquantel
medication in school-age children. An analysis was con-
ducted to evaluate the potential of a questionnaire applied
separately to children with and without a history of
praziquantel medication.
MATERIALS AND METHODS
Cross sectional surveys on S. mansoni infection were
conducted among Tanzanian children three times before and
after mass treatment. The first questionnaire survey with
stool examination was carried out in January and February
2001, and mass treatment was administered immediately af-
ter the survey. One month later, an additional stool exami-
nation for evaluation of efficacy of treatment was conducted.
The second questionnaire survey with stool examination
was carried out in February and March 2002, about one
year after the treatment.
Area studied: The study area was Lower Moshi located in
the southern part of the suburbs of Moshi Town in Kiliman-
jaro Region, Tanzania. The annual climate is divided into
four periods: the long rainy season from March to June,
cool dry season from July to October, short rainy season in
November, and hot dry season from December to February.
The main economic activity is wet-rice cultivation. The
land is well developed for paddy cultivation with irrigation
canals where water flows throughout the year. People usu-
ally cultivate crops three times a year. An agricultural de-
velopment project supported by Japan International Coop-
eration Agency (JICA) has been conducted in this area since
the 1970s.
Study population: The study was conducted in four pri-
mary schools; Mabogini, Rau River, Oria and Chekereni.
There were 1,033 children registered in grades three and
four in 2001.
Stool examination: A stool sample container was distrib-
uted to each child for collection of stool on the next day or
the day after. Double 20 mg Kato-Katz thick smears [25]
were processed and examined for the ova of S. mansoni ,
Ascaris lumbricoides, Trichuris trichiura , and hookworms
by trained technicians and the authors. The number of eggs
found in the samples was expressed as eggs per 1 gram
(EPG) to reveal the intensity of infection. The presence of
eggs was assessed for prevalence of infection. Geometric
mean was calculated for expressing intensity of groups.
Questionnaire survey: The questionnaire consisted of five
parts containing a total of 35 questions (see Tables 3 and 4
for the questionnaire contents). The first part focused on
self-diagnosis, with the question “Do you think you have
bilharzia (Kichocho in local Swahili language)?” The sec-
ond part dealt with 18 self-reported clinical manifestations
self-recognized during the last two weeks prior to the sur-
vey, including abdominal pain, diarrhea, constipation, ab-
dominal enlargement, and blood in stool. The third part
dealt with the history of contact with irrigation and river
water including swimming, bathing, fishing (mainly net-
fishing), washing clothes, fetching water, and other pur-
poses. The fourth part dealt with anamnestic information:
blood in stool in the past, experience of stool examination,
and history of anti-schistosomiasis medication. The last
part dealt with recognition and knowledge of schistosomia-
sis. The questionnaire was written in Swahili, the local lan-
guage. Under the supervision of a Tanzanian doctor, a field
assistant read out the questions to the children in groups of
20, and the children completed the forms individually.
Children recorded their answers as ‘yes’, ‘no’ or ‘don’t
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know’. We combined ‘no’ and ‘don’t know’, and used the
percentage of ‘yes’ replies to determine prevalence.
Treatment: Mass treatment with praziquantel was carried
out in the schools under the supervision of a medical nurse
in February 2001. Each child received 40 mg/kg of
praziquantel. At the end of the study, the infected children
were treated again. For the treatment of intestinal parasitic
infection, we used mebendazole at a dose of 600 mg per
person as a mass treatment in February 2001 and as a selec-
tive treatment in March 2002.
Analysis: The results of the study were analyzed using the
SPSS (version 11.5) software package. First, the preva-
lence of infestation by age and sex and by all the 35 vari-
ables in the questionnaire was calculated. Then the odds ra-
tios (ORs) of infection were calculated and tested by Chi-
square analysis. By using the variables correlated at less
than the 0.10 level in univariate analyses, logistic regression
analysis was conducted to assess the associations with in-
fection after correcting for age and sex. The sensitivities
and specificities of logistic regression models were calcu-
lated to assess the effectiveness of the questionnaire as a
tool for individual diagnosis of infection. The analysis was
conducted separately for those who had received treatment
before the mass treatment and for those who had never re-
ceived the treatment.
Ethical guidelines: This study was part of an epidemiologi-
cal survey permitted by the National Institute of Medical
Research, Ministry of Health, United Republic of Tanzania.
We started the program by explaining the outline of the
study to local authorities. Then we explained orally the
purpose and methods of the study to the school children,
their parents and teachers at school assemblies. At mass
treatment, we treated all children who desired treatment ir-
respective of enrollment in the study. We treated infected
children again for S. mansoni and other helminthes at the
end of the study in March 2002. Informed consent was not
obtained in written form.
RESULTS
Number of subjects for analysis: Out of 1,033 children
registered in grades 3 and 4 in the 4 schools, demographic
data such as sex and age were obtained from 830 children
(417 males and 413 females, aged 7 to 17). Out of these
830 children, 267 (32.2%) had undergone three stool ex-
aminations, mass treatment after the first survey, and two
questionnaires. The present analysis is restricted to these
267 children. The number of children by age and sex is
shown in Table 1 with prevalence of S. mansoni infection.
No significant difference in age or sex were observed be-
tween the 267 children and the rest of the 830 children.
Prevalence and the intensity of S. mansoni infestation:
Among the 267 children, the prevalence of schistosomiasis
was 67.4% and the mean intensity of schistosoma eggs in
feces was 29.9/g at the first stool examination prior to mass
treatment (Figure 1). The prevalence and intensity were not
significantly different either by sex or by age. The preva-
lence decreased to 6.4% (McNemar test, p < 0.001) and the
mean intensity to 0.3/g (t-test, p < 0.001) one month after
the mass treatment (2nd fecal analysis). However, the preva-
lence increased to 27.0% (McNemar test, p < 0.001) with a
slight increase in the mean intensity to 2.5/g (t-test, p <
0.001) one year after the treatment (3rd fecal analysis), al-
though this prevalence and intensity were still significantly
lower than those prior to mass treatment (McNemar test p <
0.001, t-test p < 0.001, respectively). The mean EPG calcu-
lated from only positive samples decreased from 160.8/g (n
= 180) to 74.8/g (n = 17) by mass treatment and then in-
creased to 105.2/g (n = 72) one year after the treatment.
The prevalence of heavy infection (more than 400 EPG) de-
Table 1 The number of children and prevalence of S. mansoni infection before mass-
treatment by age and sex
Boys Girls
Age Examined Infected Prevalence (%) Examined Infected Prevalence (%)
7-9 9 7 (77.8) 17 11 (64.7)
10 30 20 (66.7) 29 21 (72.4)
11 41 29 (70.7) 50 31 (62.0)
12 32 23 (71.9) 19 9 (47.4)
13 15 10 (66.7) 10 7 (70.0)
14-17 11 9 (81.8) 4 3 (75.0)
Sub-total 138 98 (71.0) 129 82 (63.6)
In total, 267 children were examined and 180 (67.4%) were egg-positive.










































































total positive case Mean Heavy Mild and moderate
creased from 14.2% to 0.4% by treatment, then increased to
3.0% after one year.
Experience of treatment: Of the 267 children, 61 had no
history of medication for schistosomiasis before the mass
treatment, while 116 children had a medication history. The
remaining 90 children were not sure either way. The preva-
lence and intensity of infection did not differ significantly
between non-treated and treated children (59.0% and 17.6/g
for the former and 62.9% and 21.4/g for the latter) in the
first stool examination.
Prevalence of water contact activities: About 90% of chil-
dren reported having contact with irrigation/river water for
the purpose of swimming/playing, bathing, crossing water
and washing clothes, and fetching water in the first survey.
About 40% of children had contacted water for the purpose
of fishing in the first survey. The percentage of children
contacting irrigation/river water in the second survey de-
creased slightly from the first survey in all activities.
Results of questionnaire survey in relation to egg detec-
tion before mass treatment for the 267 children: Before
mass treatment, the most common symptom was “abdomi-
nal pain” (60%) followed by “headache” (52%) and “ab-
dominal discomfort” (40%). But, no manifestation showed
a significant increase with the level of intensity (Table 2).
“Constipation” and “net-fishing” showed a significant cor-
relation with infection (both p < 0.05) and “diarrhea” and
“history of blood in stool” showed borderline significance
(both, p < 0.10, by Chi-square test, Tables 3 and 4). For a
Table 2 Prevalence of signs and symptoms by the level of intensity of S. mansoni infection before mass-treatment
Manifestations
Percentage of “yes” answers in the questionnaire
Somers’ d pTotal
Level of intensity§
Negative Mild Moderate Heavy
0 epg 1 - 99 epg 100 - 399epg 400 epg<
(n=267) (n=87) (n=51) (n=91) (n=38)
abdominal pain 59.6 52.9 62.7 61.5 65.8 0.149 0.459
headache 52.4 46.0 51.0 58.2 55.3 0.130 0.415
abdominal discomfort 40.4 33.3 43.1 42.9 47.4 0.109 0.398
easy to be tired 28.8 25.3 31.4 29.7 31.6 0.451 0.834
fever 24.3 20.7 31.4 28.6 13.2 0.863 0.141
loss of appetite 20.6 20.7 27.5 16.5 21.1 0.609 0.491
cough 19.9 19.5 23.5 22.0 10.5 0.475 0.428
nausea/vomiting 18.4 16.1 21.6 20.9 13.2 0.943 0.632
constipation 17.2 10.3 27.5 19.8 13.2 0.371 0.058
diarrhea 16.5 10.3 19.6 18.7 21.1 0.085 0.303
fatigue 14.2 10.3 21.6 14.3 13.2 0.646 0.339
abdominal enlargement 14.2 9.2 19.6 17.6 10.5 0.391 0.233
dizziness/lassitude 12.4 10.3 13.7 12.1 15.8 0.482 0.845
skin rash 10.1 10.3 11.8 9.9 7.9 0.686 0.945
blood in stool 5.2 3.4 5.9 5.5 7.9 0.335 0.330
itching skin 4.5 3.4 3.9 4.4 7.9 0.383 0.348
weight loss 4.1 2.3 5.9 6.6 0.0 0.753 0.840
asthma 3.7 3.4 5.9 4.4 0.0 0.477 0.549
§ Intensity is categorized according to the definitions of WHO
Figure 1 Prevalence and intensity of S. mansoni infection be-
fore, one month after, and one year after mass treat-
ment. Solid line with circles: mean prevalence of in-
fection; Dotted line with triangles: prevalence of mild
and moderate infection (100 EPG or more); Dashed
line with square: prevalence of heavy infection (400
EPG or more); Black bars: mean intensity (geometric
mean EPG for the 267 children); Gray bars: mean in-
tensity of positive cases (geometric mean EPG of 180,
17, 72 children, respectively).
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binary logistic regression analysis using “constipation”,
“net fishing”, “history of blood in stool”, “diarrhea”, age,
and sex as independent variables, only “constipation” (odds
ratio, OR = 2.27, confidence interval, CI = 1.04 - 4.96) was
positively associated with infection (Table 5a). The predic-
tion of the model, however, was not significant.
Results of questionnaire survey in relation to egg detec-
tion at one year after mass treatment for the 267 chil-
dren: Results: “Abdominal pain”, “headache” and “ab-
dominal discomfort” remained common at one year after
the treatment. The prevalence of all signs and symptoms
except “abdominal enlargement” increased from the first
questionnaire (Table 3). The prevalence of “abdominal en-
largement” decreased from 14% before treatment to 7% at
one year after treatment. The prevalence of self-diagnosis
of S. mansoni infection was 8% before the treatment and in-
creased to 26% one year after the treatment.
“Diarrhea” and “skin rash” were significantly associ-
ated with schistosomiasis (both p < 0.05), and “bathing”
showed a borderline significant association with prevalence
(p=0.09). For a binary logistic regression analysis using
“diarrhea”, “skin rash”, “bathing”, age, and sex as inde-
pendent variables, only “diarrhea” (OR = 1.96, CI = 1.13 -
Table 3 Prevalence of self-diagnosis and 2-week-recognition of symptoms before and after treatment, and for non-treated and treated
and the odds ratio between infected and non-infected
Self-diagnosis and recognition of
symptoms
within two weeks
Percentage of “yes” answers in the questionnaire (%) Odds ratio and its 95% confidence interval



















self-diagnosis 7.7 6.7 9.0 25.8 0.90 2.09 0.53 1.15
0.314-2.586 0.204-21.382 0.144-1.957 0.623-2.107
loss of appetite 20.6 44.3 19.8 43.8 0.99 2.38 1.13 1.12
0.527-1.867 0.819-6.890 0.435-2.941 0.649-1.925
nausea/vomiting 18.4 27.9 25.0 61.4 1.26 0.99 3.72* 1.06
0.637-2.486 0.317-3.085 1.299-10.665 0.610-1.858
abdominal enlargement 14.2 29.5 5.2 7.1 1.98 9.20* 0.57 2.09
0.865-4.512 1.881-44.998 0.110-2.966 0.805-5.429
abdominal discomfort 40.4 62.3 29.3 71.5 1.56 2.82§ 1.97 0.80
0.917-2.669 0.965-8.222 0.817-4.741 0.442-1.431
abdominal pain 59.6 72.1 43.1 85.4 1.50 1.97 1.26 1.82
0.895-2.524 0.634-6.115 0.587-2.713 0.766-4.338
diarrhea 16.5 19.7 25.9 49.4 2.09§ 10.56* 1.89 1.91*
0.957-4.575 1.265-88.184 0.755-4.719 1.101-3.316
constipation 17.2 36.1 10.3 38.2 2.24* 5.25* 1.88 0.96
1.029-4.887 1.500-18.380 0.479-7.342 0.550-1.677
blood in stool 5.2 8.2 6.0 30.5 1.82 3.00 3.76 1.31
0.495-6.708 0.315-28.586 0.437-32.349 0.737-2.332
easy to be tired 28.8 57.4 25.9 41.2 1.30 2.55§ 1.89 0.88
0.729-2.318 0.890-7.279 0.755-4.719 0.505-1.524
fatigue 14.2 24.6 17.2 63.7 1.66 2.31 2.74§ 1.30
0.751-3.690 0.640-8.333 0.850-8.808 0.734-2.312
fever 24.3 45.9 26.7 58.1 1.35 1.50 2.52§ 1.29
0.731-2.509 0.534-4.214 0.979-6.484 0.740-2.243
cough 19.9 37.7 19.8 58.6 1.03 1.52 1.44 1.59
0.541-1.959 0.521-4.426 0.541-3.851 0.904-2.805
asthma 3.7 9.7 3.4 16.1 1.13 1.44 1.80 1.21
0.286-4.492 0.242-8.524 0.181-17.869 0.593-2.479
weight loss 4.1 4.9 4.3 32.2 2.24 1.41 2.43 0.75
0.473-10.582 0.121-16.470 0.263-22.522 0.415-1.363
dizziness/lassitude 12.4 23.0 14.7 50.2 1.33 1.33 3.16§ 1.07
0.591-3.006 0.387-4.592 0.854-11.725 0.622-1.834
skin rash 10.1 18.0 12.1 30.3 0.96 0.80 2.37 1.85*
0.414-2.241 0.215-2.979 0.621-9.008 1.051-3.273
headache 52.4 68.9 38.8 83.5 1.47 0.78 2.54* 1.13
0.878-2.456 0.255-2.371 1.111-5.788 0.537-2.375
itching skin 4.5 3.3 8.6 43.8 1.47 0.69 2.52 1.12
0.389-5.586 0.041-11.505 0.510-12.472 0.649-1.925
*: significant at 0.05 level
§: borderline significant at 0.1 level
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3.43) was positively associated with infection (Table 5d).
The prediction of the model, however, was not significant.
The level of intensity of infection was also related with “di-
arrhea”, increasing from 45% of negative children, to 52%
of lightly infected children, to 66% of moderately infected
children and to 75% of heavily infected children (Somers’d
test, p < 0.05, data not shown).
Results of questionnaire survey in relation to egg detec-
tion before mass treatment for the 61 non-treated and
116 treated children: Next, we compared the 61 non-
treated and 116 treated children. In children without a his-
tory of medication for schistosomiasis, “diarrhea”, “consti-
pation”, “abdominal enlargement”, and “recognition of
blood in stool” were significantly associated with schistos-
omiasis by univariate analyses. “Abdominal discomfort”,
“easy to be tired”, and “recognition of the disease (yes to
the question “Have you ever heard of bilharzia?”)” were as-
sociated with borderline significance in these children (Ta-
bles 3 and 4). Recognition of blood in stool over the past
two weeks was not significant, but a history of this recogni-
tion was significant in the non-treated children.
Among the 116 children with a medication history,
meanwhile, “nausea/vomiting”, “headache”, recognition of
the disease, and knowledge of the disease (yes to the ques-
tion “Do you know what bilharzia is?”) were significant,
Table 4 Questionnaire of history of wild water contact, knowledge and recognition, experience of fecal examination, fecal blood
hisotry and treatment before and after treatment, and for non-treated and treated and the odds ratio between infected and non-
infected
Proportion of answering “yes” (%) Odds ratio and its 95% confidence interval




















any purpose 91.0 96.7 87.1 83.7 0.39 1.46 0.23* 1.63
0.128-1.165 0.087-24.468 0.048-1.051 0.716-3.733
swimming/playing 90.5 88.1 87.5 53.6 0.80 1.11 0.62 1.12
0.317-2.004 0.224-5.463 0.178-2.162 0.649-1.922
bathing 91.7 91.5 89.4 49.8 0.77 2.36 0.52 1.60§
0.289-2.074 0.363-15.309 0.129-2.083 0.926-2.764
fishing 38.7 22.0 10.6 17.6 1.84* 0.75 0.79 1.34
1.056-3.220 0.217-2.594 0.225-2.788 0.677-2.655
crossing the water 92.9 94.9 85.6 36.7 0.99 0.72 0.70 1.44
0.357-2.729 0.061-8.387 0.222-2.227 0.832-2.509
washing clothes 94.1 96.6 87.5 59.2 0.70 1.48 0.40 1.55
0.218-2.283 0.088-24.847 0.103-1.551 0.878-2.722
fetching water 88.5 84.7 89.4 54.3 0.88 1.20 0.83 1.25
0.381-2.018 0.287-5.021 0.226-3.023 0.724-2.160
for agricultural purpose 87.7 84.7 84.6 55.8 1.10 1.20 0.44 1.07
0.501-2.416 0.287-5.021 0.131-1.467 0.618-1.838
for animal husbandry 78.3 67.8 75.0 29.2 0.77 0.26* 0.58 0.83
0.400-1.471 0.075-0.945 0.223-1.480 0.451-1.516
Anamnestic information
Have you ever had blood in stool? 23.0 23.0 28.7 no data 2.08§ 5.75* 1.94 no data
0.985-4.392 1.158-28.551 0.769-4.883
Have you ever taken medication
for schistosomiasis?
60.7 0 100.0 72.2 1.07 (-) 1.00 1.30
0.588-1.947 (-) (-) 0.697-2.438
Have you ever taken fecal exami-
nation?
83.9 50.8 No data 95.5 1.22 0.92 (-) 1.11
0.556-2.656 0.333-2.562 (-) 0.293-4.231
Recognition and knowledge on the disease
Have you ever heard of disease of
bilharzia?
83.1 50.8 87.8 79.6 1.50 2.79§ 0.11* 1.20
0.774-2.906 0.971-8.034 0.014-0.894 0.598-2.391
Do you know what bilharzia is? 68.4 23.0 78.3 47.9 1.07 2.02 0.18* 1.17
0.617-1.860 0.553-7.367 0.050-0.639 0.676-2.014
Contacting with river water causes
bilharzia?
34.7 16.9 43.9 16.1 1.22 (-) 0.84 0.79
0.702-2.116 (-) 0.393-1.803 0.368-1.703
Drinking river water causes bilhar-
zia?
22.4 15.3 36.8 62.2 1.11 (-) 0.98 1.11
0.592-2.084 (-) 0.445-2.137 0.631-1.937
*: significant at 0.05 level
§: borderline significant at 0.1 level
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but abdominal manifestation was not significant (Tables 3
and 4). “Fever”, “dizziness”, “fatigue” and “contact with
river water for any purpose” showed borderline significance.
We examined the effect of treatment on selected mani-
festations using binary logistic regressions explaining S.
mansoni infection for the 61 non-treated children (Table 5b)
and for the 116 treated children (Table 5c). In the non-
treated children, “diarrhea” (p = 0.007, OR = 32.0, CI =
2.54 - 403.3) and “abdominal enlargement” (p = 0.003, OR
= 15.2, CI = 2.55 - 90.1) were significantly associated with
infection, and the model prediction was significant (Chi-
square = 26.98, p < 0.001). The sensitivity and the specific-
ity of the logistic predictive model were 86.1% and 64.0%,
respectively.
In the treated children, only knowledge of the disease
was significantly and negatively associated with prevalence,
and the prediction was significant (the model Chi-square =
10.085, p = 0.018) (Table 5c). But, the specificity of the
model prediction was very low (2.4%), while the sensitivity
was 100%.
Other parasitic infections: The prevalence of eggs of A.
lumbricoides , T. trichiura and hookworm was 6.7%, 10.9%,
and 9.0% respectively in the first examination. It declined
to 5.3%, 4.9% and 4.1% respectively one year after mass
treatment. At the first survey, A. lumbricoides infection was
correlated with S. mansoni infection (Chi-square = 9.329, p
= 0.002), but it was not significantly associated with any
sign or symptom of S. mansoni infection. Hookworm in-
fection was correlated with “constipation”. However, it did
not correlate with S. mansoni infection. T. trichiura infec-
tion showed no correlation with S. mansoni infection or
with any sign or symptom.
DISCUSSION
The present study was conducted in a high endemic
area according to the WHO definition [4], the prevalence of
schistosomiasis being 67.4% among school children aged
from 7 to 17 years old. The results indicated that subjective
abdominal symptoms are related with infection of S. man-
soni and that questionnaire on the subjective abdominal
symptoms can be used for the screening of S. mansoni in-
fection in children who have never undergone treatment for
S. mansoni infection. “Diarrhea” and “abdominal enlarge-
ment” correlated well with infection when the children had
Table 5 Logistic regression of S. mansoni infection with questionnaire’s items
a. Before mass-chemotherapy (all children, n = 267)
Variable Parameter estimate Standard error p Odds ratio
95.0% C.I††
Lower Upper
Constipation 0.820 0.399 0.040 2.271 1.039 4.961
Constant 0.822 1.106 0.458 2.274
Sensitivity = 100%, Specificity = 0%
b. Before mass-chemotherapy, (never-treated children, n = 61)
Variable Parameter estimate Standard error p Odds ratio
95.0% C.I.††
Lower Upper
Diarrhea 3.466 1.293 0.007 31.993 2.538 403.342
Abdominal enlargement 2.719 0.909 0.003 15.166 2.553 90.080
Constant -7.923 3.582 0.027 0.000
Sensitivity = 86.1%, Specificity = 64%
c. Before mass-chemotherapy, (ever-treated children, n = 116)
Parameter estimate Standard error P Odds ratio
95.0% C.I.††
Lower Upper
Recognition of the disease -1.671 0.655 0.011 0.188 0.052 0.679
Constant 2.862 2.001 0.153 17.488
Sensitivity = 100%, Specificity = 2.4%
d. After mass-chemotherapy, (all children, n = 267)
Parameter estimate Standard error p Odds ratio
95.0% C.I.††
Lower Upper
Diarrhea 0.675 0.284 0.017 1.964 1.126 3.425
Constant -2.232 1.193 0.061 0.107
Sensitivity = 0%, Specificity = 100%
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no history of treatment. These correlations were not seen in
children who had undergone treatment in the past, although
the prevalence and intensity of infection did not differ from
those of the non-treated children. At one year after mass
treatment, no suitable model for the prediction of S. man-
soni infection was obtained by using self-diagnosis, subjec-
tive symptoms, water contact behavior, anamnestic informa-
tion, or recognition and knowledge of the disease.
S. mansoni causes a chronic disease with various
stages and many symptoms and signs at each stage, adult
worms being present in the mesenteric veins and eggs in
various organs including the liver, lungs and gastrointestinal
tract. Deposition of eggs in the alimentary tract causes mu-
cosal lesions frequently associated with hemorrhage result-
ing in blood in the stool. The abdominal symptoms might
be influenced by adult worms in the mesenteric veins and
egg embolism scattered from the adult female worms. The
human body responds to schistosomula during acute infec-
tion or when eggs are retained in tissue [26]. Regarding
adult worms, no response has been observed around the live
worms. Colley advocated the hypothesis that praziquantel
treatment alters host-parasite relationships, leading to multi-
ple immunologic changes through the killing of adult
worms. The antigens released from dead adult worms cause
many immune responses and produce some resistance to re-
infection [27]. This hypothesis is supported by an animal
experiment using immuno-compenent and deficient mice
[28]. B cell deficient mice showed a delayed response after
praziquantel treatment, suggesting that the immunological
responses are required for the killing of adult worms during
treatment. Taken together, this evidence and our results
suggest that the abdominal manifestations become obvious
in the host who has recently been infected and not treated
by medication.
The association between intensity of infection and
morbidity was frequently reported. It was shown that com-
plaints of “abdominal pain” and “blood in stool” correlated
significantly with S. mansoni egg counts in a high preva-
lence village [11]. Heavily infected individuals frequently
complained of “abdominal pain” [14]. Our study, however,
did not confirm any correlation between intensity of infec-
tion and the prevalence of abdominal symptoms. The rea-
son for this is not clear. “Abdominal discomfort”, “diar-
rhea”, “constipation”, “easy to be tired” and “abdominal en-
largement” were associated with the level of intensity of in-
fection (Somers’d test, p = 0.021, 0.003, 0.004, 0.038 and <
0.001, respectively) in the non-treated children. Almost all
of these children had abdominal manifestations. On the
other hand, “dizziness/lassitude”, “nausea/ vomiting” and
“headache” were associated with the level of intensity of in-
fection (Somers’d test, p = 0.030, 0.014 and 0.018, respec-
tively) in the treated children.
One of the limitations of the present study is that it ex-
amined only the ova of helminthes in fecal specimens and
did not determine other causes of “diarrhea” and “abdomi-
nal enlargement” such as protozoan or bacterial intestinal
infection. Since abdominal manifestations are non-specific,
it is impossible to overrule other causes. In fact our results
show that the infection of hookworm causes “constipation”
as an abdominal symptom, although the prevalence was not
high. The intestinal parasitic infestation did not contribute
significantly to the abdominal manifestations in our study
because of its low prevalence, although the hookworm in-
fection was significant as a cause of “constipation”. From
this viewpoint, the abdominal manifestation should be ap-
plied while ruling out other intestinal infections and infesta-
tions.
“Blood in stool” is well documented as the most nota-
ble subjective sign of S. mansoni infection. Sukuwa (1985)
and Proietti (1989) reported that “blood in stool” had the
highest specificity (94.9%) [17] and the highest positive
predictive value (38.9%) [18] among the symptoms. In the
present study, however, “recognition of blood in stool” did
not prove to be a specific sign of infection. With regard to
the individual perception of clinical manifestations, the only
reliable variables identified were “diarrhea” and “abdominal
enlargement”. The reason may be that our study population
was limited to school children while the previous studies in-
cluded adults.
In the variables of risk factors such as self-diagnosis,
water contact history, anamnestic information, and recogni-
tion and knowledge of the disease, we did not identify any
significant variable that could be used for individual diag-
nosis. The use of risk factors has been reported to be lim-
ited in its potential to identify the infection of S. mansoni .
Utzinger (2000) argued that recalled water-contact patterns
collected by questionnaire might be useful for self-
diagnosis of schistosomiasis, showing sensitivity and speci-
ficity of “crossing the river” to be 61-70% and 47-52%, re-
spectively, and those of “swimming/bathing” to be 77-81%
and 37-68% respectively [23]. According to Brooker
(2001), the reported “swimming” had 80% sensitivity and
83% specificity [21]. However, Lima e Costa (1998)
pointed out that sociodemographic variables and water con-
tact activities associated with S. mansoni infection differed
among the study areas, thus their validity for diagnosis of
infection similarly differed among the areas [22]. Unlike
previous studies, water contact behavior was not correlated
with infection in our study. The reason might be that we
did not define the period of the behaviors in the question-
naire and therefore that many children reported having con-
tact with the irrigation/river water.
１５０
After a series of mass treatments in high prevalence ar-
eas, prevalence will decrease considerably. Subsequently,
the school-based mass treatment approach might be re-
placed by selective treatment, and children can be moni-
tored for re-infection individually. But as the present study
showed, diagnosis by questionnaire becomes inapplicable
once children take medication. Although stool examination
is the most reliable method for individual identification of
S. mansoni infection in an area of low intensity infection,
other simple, rapid and cost-effective individual diagnostic
methods are still required in areas where laboratory exami-
nation has not been established. Moreover, it is imperative
that old-fashioned questionnaire analysis be analyzed for
usefulness for schistosomiasis using praziquantel-resistant
clone [29].
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